Clinical/Scientific Advisory Panel
Professor Gerald Holtmann MD, PhD, MBA, FRACP, FRCP, FAHMS
Gerald Holtmann is an Academic Gastroenterologist with substantial managerial and leadership experience inside and outside the academic sector.
He is Director of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and Associate Dean Clinical for the Faculty of Health & Behavioral Sciences and for the Faculty of Medicine at the University of Queensland. In addition, he also serves as Director on the Boards of the West Moreton Hospital and Health Service and the Gallipoli Foundation. Prior to relocation to Brisbane, he completed a 3-year term as CEO and Medical Director of the University Hospital Essen, Germany and has served several years on the Board of this organisation with an annual budget of over $1b. Before that he was Director of the Department of Gastroenterology, Hepatology and General Medicine at the Royal Adelaide Hospital with a joint appointment as Professor of Medicine at the University of Adelaide.
Prof Holtmann has completed his Clinical Training in Medicine and Gastroenterology at the University Hospital Essen, Germany with a fellowship at the Mayo Clinic, Rochester, MN. He is a Fellow of the Royal College of Physicians (London), the Royal Australasian College of Physicians and the Australian Academy of Health and Medical Sciences. In addition to his training in Medicine and Gastroenterology he completed a Master of Business Administration at the University of South Australia and is certified by the German Board of Physicians in Medical Informatics and Biostatistics.
His research in the field of Gastroenterology with a focus on Neurogastroenterology has been published in leading journals including the New England Journal of Medicine, The Lancet, Gut and Gastroenterology and has attracted more than 20,000 citations.
Dr Peter Nash
Peter Nash is Associate Professor in the Department of Medicine at the University of Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast.. Dr Nash has Chaired the Professional Affairs Committee and the Therapeutics Committee , and serves on the Scientific Advisory Committee of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He remains on the International Steering Committee for GRAPPA.
Dr Nash and his group at the Rheumatology Research Unit have been involved with pivotal registration clinical trials for all modern targeted biologic therapies and osteoporosis therapies. He has published more than 100 peer-reviewed papers and 5 book chapters, and acts as reviewer for a number of journals and serves on the editorial board of Annals of the Rheumatic Diseases and RMD Open. His special interests include metabolic bone disease and novel therapeutics.